MedTrace Logo

Periodontitis Severity and Associated Factors Among Egyptian Males and Females

NCT07721337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2026-07-23

No results posted yet for this study

Summary

This cross-sectional study aims to evaluate and compare the severity of periodontitis between a group of Egyptian males and females. Additionally, the study explores the association between periodontitis severity and various lifestyle and systemic factors, including oral hygiene habits, dietary patterns (vegetable and fruit intake), and Body Mass Index (BMI).

A total of 380 participants (equal numbers of males and females) are examined to determine their periodontitis stage according to the 2017 AAP/EFP classification. Participants also complete a comprehensive questionnaire assessing their daily habits and physical measurements. The findings of this study will help understand gender-based differences in periodontitis severity and identify potential lifestyle risk factors in the Egyptian population.

Conditions

  • Periodontitis

Interventions

OTHER

Clinical Periodontal Examination and Questionnaire

This is an observational study. The intervention consists of a one-time comprehensive clinical periodontal examination to determine the periodontitis stage (according to AAP/EFP 2017 guidelines) and a detailed lifestyle questionnaire completed by the participants. No therapeutic interventions or new treatments are administered.

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Noura Abdel Rahman, PhD · Faculty of Dental Medicine, Al-Azhar University

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07721337 on ClinicalTrials.gov